H&N patients haven't seen innovation in the disease area for the past 10 years. Those patients face stigma and lack of clear pathways to get early treatment. Are we all doing enough to accelerate the process? How do we make others SEE them?
THE TALKS has decided to get the professionals from academics and industry alongside entrepreneurs under on stage to discuss on areas such as neuro-immunology, oxidative stress & neurological disorders.